{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:08:54Z","timestamp":1793279334714,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.041","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:45:41Z","timestamp":1782542741000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection Versus Laser"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4587-6201","authenticated-orcid":false,"given":"FRANCISCO","family":"ALTAMIRANO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-110X","authenticated-orcid":false,"given":"MELISSA","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CELINE","family":"CHAAYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-360X","authenticated-orcid":false,"given":"SANDRA","family":"HOYEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JU HYUN","family":"JEON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0254-6284","authenticated-orcid":false,"given":"REEM","family":"ALAHMADI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IASON S.","family":"MANTAGOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-1472","authenticated-orcid":false,"given":"CAROLYN","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AUDINA M.","family":"BERROCAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EFREN","family":"GONZALEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-0922","authenticated-orcid":false,"given":"DEBORAH K.","family":"VANDERVEEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RYAN","family":"GISE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-6104","authenticated-orcid":false,"given":"NIMESH A.","family":"PATEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2026.06.041_bib0001","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ophtha.2023.04.004","article-title":"Causes of childhood blindness in the United States using the IRIS\u00ae registry (intelligent research in sight)","volume":"130","author":"Lim","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.06.041_bib0002","first-page":"233","article-title":"Final results of the Early Treatment for retinopathy of prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"12","key":"10.1016\/j.ajo.2026.06.041_bib0003","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/bjophthalmol-2020-317467","article-title":"Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort","volume":"105","author":"Yu","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.041_bib0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results","volume":"106","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.041_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of Intravitreal Bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.041_bib0006","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ophtha.2025.01.004","article-title":"Evaluating the utility of initial examinations in retinopathy of prematurity","volume":"132","author":"Altamirano","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.06.041_bib0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2023.03.007","article-title":"Retinopathy of prematurity outcomes of neonates meeting only a single screening criterion: proposal of the TWO-ROP algorithm","volume":"252","author":"Patel","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.041_bib0008","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1542\/peds.2004-1915","article-title":"Age terminology during the perinatal period","volume":"114","author":"Engle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2026.06.041_bib0009","article-title":"The incidence and timing of treatment-requiring retinopathy of prematurity in nanopremature and micropremature infants in the United States","author":"Scarboro","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.041_bib0010","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.ajo.2026.06.041_bib0011","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ajo.2026.06.041_bib0012","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.041_bib0013","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.06.041_bib0014","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.041_bib0015","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ophtha.2022.05.019","article-title":"Low- and very low-dose bevacizumab for retinopathy of prematurity","volume":"129","author":"Freedman","year":"2022","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2026.06.041_bib0016","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ophtha.2022.06.042","article-title":"A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity","volume":"129","author":"Chang","year":"2022","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.041_bib0017","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.06.041_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2021.110310","article-title":"The effects of aging on the mechanical properties of the vitreous","volume":"119","author":"Levin","year":"2021","journal-title":"J Biomech"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.041_bib0019","first-page":"1442","article-title":"Clinical presentations and outcomes of pediatric rhegmatogenous retinal detachment: 11 years\u2019 Experience at a tertiary eye center","volume":"60","author":"Alabbasi","year":"2024","journal-title":"Med (Kaunas)"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.041_bib0020","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.oret.2025.01.012","article-title":"A meta-analysis of Intravitreal Ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity","volume":"9","author":"Baiad","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.041_bib0021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10103-011-1021-z","article-title":"Laser treatment for retinopathy of prematurity","volume":"28","author":"Houston","year":"2013","journal-title":"Lasers Med Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.041_bib0022","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/0301-4738.71689","article-title":"Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia","volume":"58","author":"Jalali","year":"2010","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.041_bib0023","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/aos.14406","article-title":"Inadequate laser coagulation is an important cause of treatment failure in type 1 retinopathy of prematurity","volume":"98","author":"Spandau","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.041_bib0024","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.041_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7180\/kmj.23.108","article-title":"What is the effect of deferred laser treatment on reactivated retinopathy of prematurity after anti-VEGF injection?","volume":"38","author":"Jang","year":"2023","journal-title":"KMJ"},{"issue":"12","key":"10.1016\/j.ajo.2026.06.041_bib0026","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.oret.2025.05.026","article-title":"Timing of retinopathy of prematurity diagnosis and treatment in micro-premature and nano-premature infants during inpatient screening","volume":"9","author":"Yuan","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"26","key":"10.1016\/j.ajo.2026.06.041_bib0027","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.1080\/14767058.2022.2122035","article-title":"The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization","volume":"35","author":"Siffel","year":"2022","journal-title":"J Matern-Fetal Neonatal Med"},{"issue":"S1","key":"10.1016\/j.ajo.2026.06.041_bib0028","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.041_bib0029","article-title":"Extreme prematurity: risk and resiliency","volume":"52","author":"Taylor","year":"2022","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.ajo.2026.06.041_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajo.2025.08.004","article-title":"Retinopathy of prematurity in the extremely premature: disease burden, treatment approaches, and visual outcomes in micro- and nano-premature infants","volume":"280","author":"Yuan","year":"2025","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:31:54Z","timestamp":1788280314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S0002939426003491"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.041","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates, Timing, and Predictors of Retreatment Across Risk-Cohorts in Retinopathy of Prematurity: Intravitreal Bevacizumab Injection Versus Laser","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}